Stem Cell Medicine Patents – Insights & Stats (Updated 2025)

Stem Cell Medicine has a total of 64 patents globally, out of which 22 have been granted. Of these 64 patents, 32% patents are active. The United States of America is where Stem Cell Medicine has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the United States of America seems to be the main focused R&D centre while Israel is the origin country of Stem Cell Medicine.

Stem Cell Medicine was founded in 2010. Stem Cell Medicine is a biotechnology company specializing in developing advanced cell therapy products aimed at treating neurological disorders. The company focuses on conditions such as multiple sclerosis, chronic pain, and neuromuscular injuries.

Do read about some of the most popular patents of Stem Cell Medicine which have been covered by us in this article and also you can find Stem Cell Medicine patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Stem Cell Medicine patent portfolio.

How many patents does Stem Cell Medicine have?

Stem Cell Medicine has a total of 64 patents globally. These patents belong to 8 unique patent families. Out of 64 patents, 21 patents are active.

How Many Patents did Stem Cell Medicine File Every Year?

Stem Cell Medicine Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantStem Cell Medicine Applications FiledStem Cell Medicine Patents Granted
20252
20242
20232
20226
20216
20201
201893
2017133
201623
201511

How many Stem Cell Medicine patents are Alive/Dead?

Worldwide Patents

Active and Inactive Patents of Stem Cell Medicine

How Many Patents did Stem Cell Medicine File in Different Countries?

Stem Cell Medicine Patent Filing in Top 10 Countries

Countries in which Stem Cell Medicine Filed Patents

CountryPatents
United States of America9
Europe (EPO)7
Japan6
China6
Israel6
Canada5
Australia5
Germany3
Austria3
Brazil2
Hong Kong (S.A.R.)2
Korea (South)1
India1

Where are Research Centers of Stem Cell Medicine Patents Located?

R&D Centers of Stem Cell Medicine

10 Best Stem Cell Medicine Patents

US20130052169A1 is the most popular patent in the Stem Cell Medicine portfolio. It has received 24 citations so far from companies like Allosource, International Cell Technologies and Good Start Genetics Inc.

Below is the list of 10 most cited patents of Stem Cell Medicine:

Publication NumberCitation Count
US20130052169A124
WO2018002930A122
WO2013042122A121
WO2013042121A16
US20160122709A15
US20140304012A15
CN110573170A3
US9474744B23
US20230018711A12
US9345691B22

 What Percentage of Stem Cell Medicine US Patent Applications were Granted?

Stem Cell Medicine (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 has been granted leading to a grant rate of 66.67%.

Below are the key stats of Stem Cell Medicine patent prosecution at the USPTO.

Which Law Firms are Managing US Patents for Stem Cell Medicine?

Law FirmTotal ApplicationsSuccess Rate
Rothwell Figg Ernst & Manbeck Pc866.67%

What are Stem Cell Medicine key innovation segments?

What Technologies are Covered by Stem Cell Medicine?

The chart below distributes patents filed by Stem Cell Medicine in different countries on the basis of the technology protected in patents. It also represents the markets where Stem Cell Medicine thinks it’s important to protect particular technological inventions.

R&D Focus: How has Stem Cell Medicine search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Stem Cell Medicine?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.